Fig. 4.

fSCIG administration by age subgroup at inclusion and 12 months. a) Administration setting; b) Infusion administrator. Note: Among the 11 patients in the ramp-up phase at inclusion, 7 patients (63.6%) received their most recent fSCIG infusion at the doctor’s office and 4 patients (36.4%) at the hospital. Most patients (81.8% [9/11]) received their most recent infusion from a nurse, 1 patient (9.1%) from a physician, and 1 patient (9.1%) self-administered. Inner circle denotes at inclusion; outer circle denotes at 12 months. Data labels are number of patients. fSCIG, facilitated subcutaneous immunoglobulin